The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Excellent synopsis Merchantbanker, thank you. It’s wonderful to see true insight on this board, as opposed to “the tales of kebabs” which the other board has degraded to.
Anyone who doesn't know a lot about Mologic, see below..... this is what you should be excited about.
Backed by Gates Foundation, UK Government, Welcome Trust and Foundation for Innovative New Diagnostics
In 2015, the Gates Foundation approached Mologic to create the Centre for Advanced Rapid Diagnostics (CARD). CARD was set up with a $5m grant
Recently awarded $27m by the Gates foundation. The single largest health grant for Covid.
Covid-19 - A dual rapid test to detect viral antigens in saliva and IgM and IgG antibodies in a fingerprick of blood. The device will be made available rapidly at scale in a self test format to mitigate the effects of the current pandemic.
https://mologic.co.uk/our-core-markets/global-health/
Anyone that has never seen this article it's worth a read from April. It mentions Mologic antigen and antibody. 1 out of 2 in the bag.
https://www.360dx.com/infectious-disease/immunoassays-coronavirus-testing-including-self-tests-targeted-mologic#.X2NQzmhKiUk
Most people really do not appreciate what a big deal it is to have access to Mologic's tests. These are really at the cutting edge of the industry. Mologic have one of the founders of the clear blue pregnancy test, the first test of it's kind.
Colin has selected to work with Mologic's tests for a reason. They have proven expertise and proven success. 80% of our capacity reserved for these tests for a reason.
The lateral flow antigen device has been used in heathrow trials. The antibody device is a triple antibody test. These guys are not out there with methods that have only been tested in the lab trying to create value in their stock price, they are only interested in delivering solutions to tackle health problems.
Mologic test is worth £2.50 a test to ODX on 50% margin of £5 selling price. What do you think manufacturing another company's test is worth to ODX? - a lot less. Today's Fincapp note for that company puts the chance of success at 70% which is likely overstated rather than under.
Today has shown so many misconceptions that investors currently have. Our Mologic agreement is one of the most undervalued bits of business out there. They are material tech transfers giving us access to brand their developed products as Omega's. Omega are not just a manufacturer they are adding products to their portfolio to brand under the Visitect name. High margin products. The current planned manufacturing capacity is miniscule compared to the potential of the products already in the portfolio. I am backing Mologic to come forward with some announcements on Antigen tests very soon.